Correlation Between PaxMedica, Common and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PaxMedica, Common Stock and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on PaxMedica, Common and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Cardio Diagnostics.
Diversification Opportunities for PaxMedica, Common and Cardio Diagnostics
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between PaxMedica, and Cardio is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between PaxMedica, Common and Cardio Diagnostics
Given the investment horizon of 90 days PaxMedica, Common Stock is expected to under-perform the Cardio Diagnostics. But the pink sheet apears to be less risky and, when comparing its historical volatility, PaxMedica, Common Stock is 1.99 times less risky than Cardio Diagnostics. The pink sheet trades about -0.09 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 130.00 in Cardio Diagnostics Holdings on September 6, 2024 and sell it today you would lose (100.00) from holding Cardio Diagnostics Holdings or give up 76.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 27.52% |
Values | Daily Returns |
PaxMedica, Common Stock vs. Cardio Diagnostics Holdings
Performance |
Timeline |
PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardio Diagnostics |
PaxMedica, Common and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PaxMedica, Common and Cardio Diagnostics
The main advantage of trading using opposite PaxMedica, Common and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |